View Post

Cancer spread could be stopped by common cold medicine, scientists discover

In In The News by Barbara Jacoby

By: Tom Embury-Dennis From: independent.co.uk A drug used to treat the common cold could be used to stop the spread of bladder cancer, a study has found. Researchers in Japan found that a nonsteroid anti-inflammatory drug supressed the spread of the cancer in mice and also reduced its resistance to chemotherapy. The results raise hopes of a cure for a disease …

View Post

Nearly 1 in 12 patients with a common cancer develop a second, unrelated malignancy

In In The News by Barbara Jacoby

By: Kim Irwin From: ucla.edu Reported by: Redington Life Sciences News UCLA researchers have identified the incidence and long-term outcomes of patients who develop second, unrelated cancers, resulting in a data set that they say sheds new light on the way cancer survivors may need to be monitored post-disease. The researchers identified more than 2.1 million patients from the Surveillance, …

View Post

ASCO 2016: Roche’s Latest Tecentriq Results Underline Potential to Dominate Bladder Cancer Market

In In The News by Barbara Jacoby

As explored in an abstract presented at the 2016 American Society of Clinical Oncology (ASCO) conference, the launch of Roche’s recently approved PD-1 immune checkpoint inhibitor Tecentriq (atezolizumab) will usher in a dramatic change in the treatment paradigm of metastatic bladder cancer, according to an analyst with research and consulting firm GlobalData. The company’s most recent bladder cancer report states …

View Post

Roche’s Atezolizumab Could Spur Long-awaited Bladder Cancer Treatment Innovation, says GlobalData Analyst

In In The News by Barbara Jacoby

Atezolizumab poised to become a major bladder cancer therapy in the race for FDA approval, following positive Phase II trial results The drug will face strong competition in the bladder cancer treatment arena, especially from Bristol-Myers Squibb’s Opdivo and Merck & Co.’s Keytruda, says analyst Roche’s atezolizumab is poised to become a major bladder cancer therapy in the race for …

View Post

Bladder Cancer Breakthrough Treatment Developed after 30 Years

In In The News by Barbara Jacoby

A much-awaited breakthrough in the treatment for advanced bladder cancer has been made by scientists from the Barts Cancer Institute of Queen Mary University of London. The breakthrough, which is the first major advancement in the treatment of the dreaded disease over the past 30 years, is detailed in a paper published in the Nature journal. The research studied MPDL3280A, an …

Stay alert to bladder cancer symptoms and know that options are available

In In The News by Barbara Jacoby

By EDWARD M. EVELD From: kansascity.com Not a great topic for polite conversation, but Karla Boatright must start her story with her yearlong struggle against a determined bladder infection. That’s what she thought, anyway. Just one symptom, burning, so she and her doctor tried an antibiotic, gave it some time, then tried another. And another. And another. Nearly a year …

Scientists propose a breast cancer drug for bladder cancer patients

In In The News by Barbara Jacoby

From: MedicalXpress.com Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors. These findings suggest that administering trastuzumab to MPUC patients with HER2 amplification could improve outcomes, just …